创新的方法来管理肝硬化中的管理
1Department of Medicine, Division of Gastroenterology & Hepatology, University Health Network, University of Toronto, Toronto, Ontario, Canada.
JHEP reports : innovation in hepatology
|May 30, 2023
概括
标准的炎治疗包括饮食和利尿剂,但耐火性炎需要先进的治疗方法. 跨内肝移植系统分流 (TIPS) 的新策略和alfapump等替代疗法为肝硬化患者提供了改善的治疗方法.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 内部医学 内部医学
背景情况:
- 在肝硬化中,标准的炎治疗包括限制和利尿剂.
- 肝硬化进展往往导致耐火性,需要二线治疗.
- 专注射可能会延迟折射性,并改善早期炎的存活率.
研究的目的:
- 审查当前和新兴的策略来管理肝硬化中的.
- 讨论跨内肝移植系统分流 (TIPS) 和患者选择的作用.
- 探索替代疗法和未来的方向,在管管理.
主要方法:
- 审查当前关于肝硬化中炎治疗的文献.
- 讨论二线疗法,包括TIPS,,白蛋白和alfapump.
- 探索新的方法,如用于个性化管理的代谢学.
主要成果:
- 提示可以解决,但携带风险,如心脏失补偿和肝脏脑病变.
- 优化的TIPS安置和抗生素 (例如,利法西明) 的预治疗可以减轻并发症.
- 阿尔法普姆为不适合TIPS的患者提供改善生活质量的服务.
结论:
- 耐火性炎的管理需要个性化的方法,平衡有效性和风险.
- 在TIPS程序和支持性疗法的进步正在改善患者的治疗结果.
- 未来的研究,包括代谢学,有望完善炎管理和预测并发症.
相关概念视频
Pleural Effusion II: Symptoms and Management
223
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
223
Chronic Pancreatitis II: Collaborative Care
117
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
117
Esophageal Varices-II: Clinical Features and Management
102
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
102
Nephrotic Syndrome III : Nursing Management
20
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
20
Nephrotic Syndrome II : Assessment and Medical Management
10
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
10
Heart Failure VI: Adjunct Therapies
17
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
17


